Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.980
-0.080 (-1.58%)
Oct 8, 2024, 4:00 PM EDT - Market closed

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $778.00K in the quarter ending June 30, 2024, a decrease of -14.97%. This brings the company's revenue in the last twelve months to $2.08M, down -52.15% year-over-year. In the year 2023, Orchestra BioMed Holdings had annual revenue of $2.76M, down -21.88%.

Revenue (ttm)
$2.08M
Revenue Growth
-52.15%
P/S Ratio
85.05
Revenue / Employee
$37,125
Employees
56
Market Cap
188.37M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.76M-773.00K-21.88%
Dec 31, 20223.53M4.32M-551.79%
Dec 31, 2021-782.00K-6.49M-113.71%
Dec 31, 20205.70M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.